Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors.
about
Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceExpression of vascular endothelial growth factor and epidermal growth factor receptor in pancreatic ductal adenocarcinomas, neuroendocrine tumours and chronic pancreatitis.The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes.Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations.Elderberries: a source of ribosome-inactivating proteins with lectin activity.The role of endoglin in post-ischemic revascularization.Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies.Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.High expression of S100A4 and endoglin is associated with metastatic disease in head and neck squamous cell carcinoma.Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
P2860
Q30884794-E5149215-751E-4F96-B2B7-F50C5351D1C5Q31170918-8F1EE6B7-5869-4CB4-A430-106F2DA354F9Q33728841-3502B034-126D-4F03-8BD1-93A3480300EDQ33772907-3BB7D4CC-2E04-49F8-A494-E63A27A4BF06Q37400665-81AC6D23-82EE-4C2E-971A-3F278DA4E1F9Q37459597-D210A8B0-CB33-4309-9892-7607562431A7Q37954333-90BF5E30-7533-4D42-B0D6-D745CFAE12A5Q38250467-3AB07F7F-2A7A-4FC3-A529-DEB8B0E0CAEAQ38342640-D28A6378-5CBC-4E66-BE32-5D3553BF3B6AQ39036151-EE584FEE-5554-4783-8165-60A2412BD893Q39401943-A7EBFBB3-D85A-4A7B-A5B9-B2E6DE55BB0DQ53502200-7C095DDB-8089-4571-B1F1-62B3EEF2A8AFQ54210210-05C4AB50-BEC2-4D62-AE5A-71EFAF0AD57AQ55536886-F2A64B27-9E2B-4727-9638-971D180A95E4
P2860
Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@ast
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@en
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@nl
type
label
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@ast
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@en
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@nl
prefLabel
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@ast
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@en
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@nl
P2093
P2860
P356
P1476
Angiogenic markers endoglin an ...... creatic neuroendocrine tumors.
@en
P2093
Cornelis Bhw Lamers
Eveline Sm de Jonge-Muller
Hein W Verspaget
Izäk Biemond
Lukas Jac Hawinkels
Patricia Kuiper
P2860
P304
P356
10.3748/WJG.V17.I2.219
P407
P577
2011-01-01T00:00:00Z